The physiological cravings that accompany addiction, along with memory cues and environment triggers specific to each patient can cause a recurrence of use or relapse. As such, effective treatment needs to address a person’s behavioral health and help them learn how to cope with stress and environmental triggers.
3 min read
3 min read
Alcohol use is very prevalent among Americans - more than half of U.S. adults drank last month - and alcohol is the third leading cause of preventable death after tobacco and poor diet/physical inactivity.1,2 When coupled with prescription opioid use, drinking becomes especially dangerous.3 Women are at high-risk of experiencing these adverse health effects, which worsen with age. A recent study illuminates the repercussions of concurrent alcohol and prescription opioid use in older women.
4 min read
At the center of America’s deadly opioid epidemic, non-pharmaceutical fentanyl appears to be finding its way into illegal stimulants that are sold on the street, such as cocaine. Adulteration with fentanyl is considered a key reason why cocaine’s death toll is escalating. Cocaine and fentanyl are proving to be a lethal combination - cocaine-related death rates have increased according to national survey data. This has important emergency response and harm reduction implications as well—naloxone might reverse such overdoses if administered in time. A recent study by Nolan et. al. assessed the role of opioids, particularly fentanyl, in the increase in cocaine-involved overdose deaths from 2015 to 2016 and found these substances to account for most of this increase.
2 min read
Today the Centers for Disease Control and Prevention (CDC) announced that new advice on their Guideline for Prescribing Opioids for Chronic Pain will be published in the New England Journal of Medicine (NEJM).
3 min read
Buprenorphine, a μ-opioid (pronounced mu-opioid) receptor partial agonist, is a highly effective, evidence-based medication for treating opioid use disorders (OUD). In order to prescribe buprenorphine, qualifying practitioners must obtain a waiver from the Drug Enforcement Agency (DEA), which places strict limits on the number of patients they may treat annually. Previous legislation and regulation meant buprenorphine treatment existed nearly entirely outside the traditional healthcare system. Despite legislation that increases the number of patients a doctor can prescribe to, and allowing individual medical providers to become certified, there is still hesitation among many providers over becoming certified to prescribe the medication, many waivered physicians do not have many patients on buprenorphine - some waivered physicians have none at all.